Conversion of locally advanced to resectable pancreatic body cancer aided by phosphorus-32 brachytherapy (OncoSil).

Autor: Welsh, Fraser, Goodwin, Bernadette, Lanka, Laxmi, Allen, Berry, Wong, Jayden, Weilert, Frank

Publikováno v: New Zealand Medical Journal; 2/17/2023, Vol. 136 Issue 1570, p78-80, 3p

AS-126: Outcomes with Bare Metal Stents in Primary Angioplasty

Autor: Liang, Michael, Puri, Aniket, Wong, Jayden, Liang, Mary, Abercrombie, Kirsty, Devlin, Gerard

Publikováno v: In The American Journal of Cardiology 2010 105(9) Supplement:54A-54A

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy.

Autor: Aye PS; Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand., Barnes J; School of Pharmacy, University of Auckland, Auckland, New Zealand., Laking G; Te Aka Mātauranga Matepukupuku Centre for Cancer Research, University of Auckland, Auckland, New Zealand., Cameron L; Department of Medical Oncology, Te Pūriri o Te Ora Regional Cancer and Blood Service, Te Whatu Ora Health New Zealand, Auckland City Hospital, Auckland, New Zealand., Anderson M; Department of Medical Oncology, Te Whatu Ora Health New Zealand Te Pae Hauuora o Ruahine o Tararua, Palmerston North Hospital, Palmerston North, New Zealand., Luey B; Wellington Blood and Cancer Centre, Te Whatu Ora Health New Zealand Capital, Coast and Hutt Valley, Wellington Hospital, Wellington, New Zealand., Delany S; Department of Oncology, Te Whatu Ora Health New Zealand Nelson Marlborough, Nelson Hospital, Nelson, New Zealand., Harris D; Oncology Service, Te Whatu Ora - Waitaha Canterbury, Christchurch Hospital, Christchurch, New Zealand., McLaren B; Southern Blood and Cancer Service, Te Whatu Ora Southern, Dunedin Hospital, Dunedin, New Zealand., Brenman E; Cancer and Haematology Services, Te Whatu Ora Health New Zealand Haora a Toi Bay of Plenty, Tauranga Hospital, Tauranga, New Zealand., Wong J; Cancer Services, Te Whatu Ora Health New Zealand Waikato, Waikato Hospital, Hamilton, New Zealand., Lawrenson R; Medical Research Centre, University of Waikato, Hamilton, New Zealand., Arendse M; Department of Pathology, Te Whatu Ora Health New Zealand Waikato, Waikato Hospital, Hamilton, New Zealand., Tin Tin S; Department of Epidemiology and Biostatistics, University of Auckland, Auckland, New Zealand., Elwood M; Department of Epidemiology and Biostatistics, University of Auckland, Auckland, New Zealand., Hope P; Lung Foundation New Zealand, Manukau, Auckland, New Zealand., McKeage MJ; Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand.; Department of Medical Oncology, Te Pūriri o Te Ora Regional Cancer and Blood Service, Te Whatu Ora Health New Zealand, Auckland City Hospital, Auckland, New Zealand.; Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand.

Publikováno v: JMIR research protocols [JMIR Res Protoc] 2024 Jul 02; Vol. 13, pp. e51381. Date of Electronic Publication: 2024 Jul 02.